Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
05/22/1990 | CA1269374A1 Diazepinones |
05/22/1990 | CA1269373A1 Thieno-triazolo-1,4-diazepino-2-carboxylic acid amides |
05/22/1990 | CA1269371A1 Polycyclic aromatic derivatives, and their use in cosmetics |
05/22/1990 | CA1269370A1 Daunomycin and adriamycin sulfono and sulfoxo analogues |
05/22/1990 | CA1269367A1 Sialosylcerebrosides and a preparation method thereof |
05/22/1990 | CA1269364A1 Substituted penem derivatives and process for their preparation |
05/22/1990 | CA1269331A1 Solid oral anticariogenic composition |
05/22/1990 | CA1269328A1 Transdermal aqueous aryl-propionic-acid derivatives medication and methods of preparing same |
05/22/1990 | CA1269327A1 Process for preventing or reversing cataract formation using protein modification reagents |
05/21/1990 | CA2003537A1 Inhibitors for glycosaminosyl transferase v |
05/21/1990 | CA2003408A1 Antiviral agents |
05/21/1990 | CA2003397A1 2(1h)-quinolinone compounds, processes for the preparation thereof and pharmaceutical composition comprising the same |
05/21/1990 | CA2003395A1 Anti-atherosclerotic diaryl compounds |
05/21/1990 | CA2003385A1 A method for enhancing the lowering of plasma cholesterol levels |
05/19/1990 | CA2003306A1 Pharmaceutical compositions comprising labdane diterpenoid derivatives and pyrimido(6,1-a)isoquinolin-4-one derivatives and their use |
05/18/1990 | CA2003261A1 Process for preparing melanogenic inhibitor, and pigmentation-lightening agent containing the same |
05/18/1990 | CA2003210A1 Anti-hyperendothelinemia agent |
05/18/1990 | CA2003120A1 Isoxazolopyridine type mevalonolactones |
05/18/1990 | CA2003091A1 Substituted oxadiaminobutanes |
05/18/1990 | CA2002965A1 Conjugate of prostaglandin and polysaccharide |
05/17/1990 | WO1990005139A1 14α,17α-ETHANO-ESTRATRIENES |
05/17/1990 | WO1990005135A2 Process for the specific synthesis of new dithiocarbamic acid esters by substituting hydroxylated sites on mono- or polyhydroxylated molecules; products obtained by this process and their application |
05/17/1990 | WO1990005133A1 Muscarinic receptor antagonists |
05/17/1990 | WO1990005130A1 2-aminocarboxylic acid derivatives, their manufacture and use as drugs |
05/17/1990 | WO1990004980A1 Drug composition |
05/17/1990 | WO1990004973A1 Treatment of myelosuppression associated with acquired immune deficiency |
05/17/1990 | WO1990004971A1 Improved viscoelastic fluid for use in surgery and other therapies and method of using same |
05/17/1990 | WO1990004970A1 Antithrombotic composition |
05/17/1990 | WO1990004968A1 Inhibition of human retroviruses |
05/17/1990 | WO1990004967A2 Topical ointment |
05/17/1990 | WO1990004966A2 Chemoprevention of electrophilic damage by mercaptopurine analogs |
05/17/1990 | WO1990004965A1 Dosage form having reduced abuse potential |
05/17/1990 | WO1990004964A1 Pharmaceutical composition for ophthalmic use comprising a water soluble acid addition salt of ibopamine |
05/17/1990 | WO1990004958A1 Anti-inflammatory active ingredients for cosmetic preparations |
05/17/1990 | WO1990004917A1 Heterocyclic peptide renin inhibitors |
05/17/1990 | WO1990003979A3 Anti-androgen compounds |
05/17/1990 | WO1990003170A3 Prostaglandin-derivatives having antithrombotic activity |
05/17/1990 | WO1990002802A3 Viral nucleotide sequences |
05/17/1990 | WO1990001927A3 Use of paf antagonists for treating autoimmune diseases |
05/17/1990 | WO1990001321A3 Method for treating and preventing loss of bone mass |
05/17/1990 | DE3844655A1 Use of imexon as immunosuppressant |
05/17/1990 | CA2002980A1 Agents for the treatment of acute and chronic obstructive respiratory passage diseases |
05/17/1990 | CA2002888A1 Heterocyclic amides |
05/17/1990 | CA2001159A1 7-oxadicycloheptane imino interphenyleneoxy substituted prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease |
05/17/1990 | CA2001028A1 7-oxabicycloheptane imino interphenylene substituted prostaglandin analogs useful in the treatment of thrombotic disease |
05/16/1990 | EP0368823A2 Biologically active lipoprotein and its use |
05/16/1990 | EP0368758A2 Zinc cysteate, its preparation and its pharmaceutical and cosmetic uses |
05/16/1990 | EP0368756A1 Dibenzocycloheptene derivatives, process for their preparation and their use as medicaments |
05/16/1990 | EP0368719A2 Novel analogs of peptidase substrates |
05/16/1990 | EP0368652A1 Imidazoquinoxalines and their preparation |
05/16/1990 | EP0368645A2 Memory-enhancing compositions containing dioxopiperidine derivatives |
05/16/1990 | EP0368640A2 Heterocyclic compounds |
05/16/1990 | EP0368534A2 Prevention of anal leakage of polyorganosiloxane fluids used as fat substitutes in foods |
05/16/1990 | EP0368464A1 Thiopene-2 carboxamide derivatives and their pharmaceutical use |
05/16/1990 | EP0368410A2 Optically active benzoxazines and bezothiazines and a process for their stereospecific preparation |
05/16/1990 | EP0368409A2 Compositions for the transdermal delivery of buprenorphine salts |
05/16/1990 | EP0368406A2 Compositions for the transdermal delivery of pharmaceutical actives |
05/16/1990 | EP0368388A2 3-Piperidinyl-1,2-benzisoxazoles |
05/16/1990 | EP0368384A1 Thiazole derivatives |
05/16/1990 | EP0368373A1 Multi-phase contraceptive preparation |
05/16/1990 | EP0368349A2 Serine analogs of BU-3608 antibiotics |
05/16/1990 | EP0368343A2 Ameliorating composition for dysmnesia |
05/16/1990 | EP0368339A2 Pharmaceutical preparation for percutaneous administration containing bunazosin or its salt |
05/16/1990 | EP0368223A2 Use of ethylene diamine tetraacetic acid as inhibitor of calcium/calmoduline-dependent protein kinase II or protein kinase C |
05/16/1990 | EP0368188A1 1,2,3,4-Tetrahydro-1,9-acridinediamines, a process for their preparation and their use as medicaments |
05/16/1990 | EP0368175A1 3S,7S-3-(Morpholinocarbonyl)-5-(2-chlorphenyl)-7,10-dimethyl-3,4-dihydro-2H,7H-cyclopenta[4,5]thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine. |
05/16/1990 | EP0368160A1 Tetralin derivatives |
05/16/1990 | EP0367974A1 Cis-complexes with a 1,3-diaminopropane derivative as a ligand, methods for their preparation and pharmaceutical agents containing such complexes |
05/16/1990 | EP0367954A1 Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics |
05/16/1990 | EP0367944A2 Ether derivative of 4-[3H] -quinazolinone, a process for the preparation thereof, and pharmaceutical compositions |
05/16/1990 | EP0367895A1 Pyrimidinyl-substituted hydroxyacids, lactones and esters and pharmaceutical compositions containing them |
05/16/1990 | EP0367888A1 2,2-Disubstituted 2,3-dihydro-1,4-benzodioxin derivatives having hypotensive activity |
05/16/1990 | EP0305297B1 Derivatives of aza-z-bicyclooctane-caboxylicacid-3, processes for their preparation and pharmaceutical compositions containing them |
05/16/1990 | EP0208755B1 Thromboxane antagonists in the treatment of hormone-dependent neoplasias |
05/16/1990 | EP0173210B1 Pellet preparation |
05/16/1990 | CN1042153A 3-aryloxymethyl-cephalosporin derivatives, their preparation and their medical use |
05/16/1990 | CN1042152A Substituted thienopyrans as antihypertensive agents |
05/16/1990 | CN1042151A Preparation for camptothecin arginine salt |
05/16/1990 | CN1042148A Anti-anxiety agents |
05/16/1990 | CN1042147A Thiochroman esters of phenols and terephthallates having retinoid-like activity |
05/16/1990 | CN1042146A Branched-chain alkyl esters of 2-(4-(2-piperidiono-ethoxy)-benzoyl)-benzoic acid, processes for their preparation and their use as spasmolytic agents |
05/16/1990 | CN1042145A Novel quinolyloxazole-2-ones useful as proteinkinase c inhibitors |
05/16/1990 | CN1042076A Method for preparing anion exchange resin delivery system |
05/16/1990 | CN1042075A Medicines for transcortical application containing steroidhormonen |
05/16/1990 | CN1042074A Prescription for anti-pus ulser agent |
05/16/1990 | CN1042071A Novel dosage form |
05/16/1990 | CN1042045A Extruder for edible anion exchange resin delivery system |
05/16/1990 | CN1007977B Process for the preparation of 7-amino-1-cyclopxopyl-6, 8-dihalogeno-1, 4-dihydro-4-oxo-3-quinolinecarboxylic acids |
05/16/1990 | CN1007959B Improves antiinfiammatory compositions and methods |
05/16/1990 | CN1007958B Process for the preparation of metal complexes of bis-indole compounds and agueous pharmaceutical compositions containing them |
05/16/1990 | CA2002814A1 Angiostatic agents |
05/15/1990 | US4925979 Flavone carboxylic acid derivatives |
05/15/1990 | US4925952 Process for preparing 1-hydroxyalkyl-5-nitroimidazoles |
05/15/1990 | US4925950 Hydroxyalkylation |
05/15/1990 | US4925932 Preparation of double sulfate salt of desoxyfructosyl serotonin and creatinine |
05/15/1990 | US4925879 Antidepressants |
05/15/1990 | US4925878 N-phenylisopropyl-n-methyl-propylvinylamines; oral administration |
05/15/1990 | US4925877 Antitumor agents, bactericides, enzyme inhibitor |
05/15/1990 | US4925874 Novel cyclopropane carboxylates |
05/15/1990 | US4925873 Prostaglandin derivatives or substituted phenylacetic acids |